Chan Henry Lee
SVP, General Counsel · 13 filings · Latest: Sep 30, 2026
BeOne Medicines Ltd.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ONC | CHAN LEE | — | May 13, 2026 | Proposed Sale | $315.07 | 1,328 | $418.4K | — | |
ONC | Chan Henry Lee | SVP, General Counsel | Apr 8, 2026 | Sale | $311.59 | 332 | $103.4K | 0 | |
ONC | Chan Henry Lee | SVP, General Counsel | Apr 8, 2026 | Option Exercise | $191.56 | 332 | $63.6K | 332 | |
ONC | Chan Henry Lee | SVP, General Counsel | Mar 11, 2026 | Sale | $300.00 | 341 | $102.3K | 0 | |
ONC | Chan Henry Lee | SVP, General Counsel | Mar 11, 2026 | Option Exercise | $191.64 | 341 | $65.3K | 341 | |
ONC | Chan Henry Lee | SVP, General Counsel | Feb 4, 2026 | Sale | $349.52 | 1,660 | $580.2K | 0 | |
ONC | Chan Henry Lee | SVP, General Counsel | Feb 4, 2026 | Option Exercise | $191.40 | 1,660 | $317.7K | 1,660 | |
ONC | CHAN LEE | — | Feb 4, 2026 | Proposed Sale | $346.38 | 4,676 | $1.6M | — | |
ONC | CHAN LEE | — | Oct 8, 2025 | Proposed Sale | $341.62 | 13,659 | $4.7M | — | |
ONC | CHAN LEE | — | Sep 10, 2025 | Proposed Sale | $351.13 | 9,010 | $3.2M | — | |
ONC | CHAN LEE | — | Aug 13, 2025 | Proposed Sale | $288.10 | 10,338 | $3.0M | — | |
ONC | CHAN LEE | — | Jul 30, 2025 | Proposed Sale | $304.60 | 920 | $280.2K | — | |
ONC | CHAN LEE | — | Jun 16, 2025 | Proposed Sale | $266.50 | 422 | $112.5K | — | |
ONC | CHAN LEE | — | Jun 6, 2025 | Proposed Sale | $256.11 | 700 | $179.3K | — | |
ONC | CHAN LEE | — | Feb 27, 2025 | Proposed Sale | $259.00 | 1,205 | $312.1K | — | |
ONC | CHAN LEE | — | Feb 21, 2025 | Proposed Sale | $244.20 | 1,202 | $293.5K | — | |
ONC | CHAN LEE | — | Sep 30, 2024 | Proposed Sale | $218.42 | 1,202 | $262.5K | — |
← Previous
Page 2 of 2